MycoBiomDB – Record Details (MyCo_2466)

Biomarker Record Details

Database ID: MyCo_2466
DB IDMyCo_2466
TitleAspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management
Year2008
PMID18227109
Fungal Diseases involvedInvasive aspergillosis
Associated Medical ConditionHematological malignancies and profound neutropenia
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceBronchoalveolar lavage fluid (BALF)
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameGM
Biomarker Full NameGalactomannan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationGermany
CohortTwo hundred patients were recruited in the study.
Cohort No.200
Age Group23–74
P ValueNone
Sensitivity1
Specificity0.938
Positive Predictive Value0.607
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismInvasive aspergillosis (IA) is a major cause of morbidity and mortality in patients with hematologic malignancies undergoing intensive cytotoxic therapy or hematopoietic stem- cell transplantation (HSCT). Due to the increasing use of high- dose chemotherapy and the application of immunosuppressive agents, such as antilymphocyte antibodies, the incidence of IA is currently rising up to 30% in some centers. Early diagnosis of IA is generally considered to be mandatory to increase survival. Clinical symptoms and radiological signs of IA, however, are mostly nonspecific and occur late in the course of the disease, making early clinical and radiological diagnosis almost impossible.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsELISA Kit- Platelia Aspergillus (Platelia Aspergillus EIA, Bio-Rad).
Assay DataNone
Validation Techniques usedFDA Approved -Platelia Aspergillus ELISA
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone